HeartWare International, Inc. (HTWR)

[cjgaddy]

2-26-15/HTWR Q4’14 Fins: Revs=$73.2mm +38%

• HeartWare Reports $73.2mm in Q4’14 Revs; 38% Incr. From Q4’13
• U.S. revenue of $41.5mmn, up 60% and Intl. revenue of $31.7mm, up 17%, compared to Q4’13
• Revenue for 2014 increased 34% to $278.4mm, from $207.9mm in ‘13
• Conference call today at 8:00amET
http://ir.heartware.com/phoenix.zhtml?c=187755&p=irol-newsArticle&ID=2020425

FRAMINGHAM, Feb. 26, 2015 HeartWare Intl. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced revenue of $73.2mm for the fourth quarter ended Dec31, 2014, a 38% increase compared to $53.1mm in revenue for the same period of 2013. For FY14, the company generated revenue of $278.4mm, a 34% increase compared to revenue of $207.9 in 2013.

During Q4, 737 HeartWare® Ventricular Assist Systems were sold globally, compared to 524 units in the fourth quarter of 2013. U.S. revenue, generated through the sale of 382 units during Q4/’14, was $41.5mm, a 60% incr. from $25.9 million in Q4’13. Revenue from Intl. markets, derived through the sale of 355 units, was $31.7 million, an increase of 17% from $27.1 million in q4’13. Currency fluctuations offset total revenue performance in Q4 by approx. $1.9mm, or 3.7%, compared to the fourth quarter of 2013. . .